Related Experiment Videos

Influenza vaccine for healthy adults?

P A Patriarca, R A Strikas

The New England Journal of Medicine

|October 5, 1995

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50-64 years of age.

Vaccine·2011

Immunizations: recommendations and resources for active patients.

The Physician and sportsmedicine·2010

Comparative immunogenicity of recombinant influenza hemagglutinin (rHA) and trivalent inactivated vaccine (TIV) among persons > or =65 years old.

Vaccine·2009

Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports·2004

Use of standing orders programs to increase adult vaccination rates.

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports·2004

Performance of US hospitals on recommended screening and immunization practices for pregnant and postpartum women.

American journal of infection control·2000

See all related articles